← Back to home

NUCLEOS(T)IDE ANALOGUE-SUPPRESSED HBEAG-NEGATIVE PATIENTS WITH CHRONIC HEPATITIS B

Clinical trials for NUCLEOS(T)IDE ANALOGUE-SUPPRESSED HBEAG-NEGATIVE PATIENTS WITH CHRONIC HEPATITIS B explained in plain language.

Never miss a new study

Get alerted when new NUCLEOS(T)IDE ANALOGUE-SUPPRESSED HBEAG-NEGATIVE PATIENTS WITH CHRONIC HEPATITIS B trials appear

Sign up with your email to follow new studies for NUCLEOS(T)IDE ANALOGUE-SUPPRESSED HBEAG-NEGATIVE PATIENTS WITH CHRONIC HEPATITIS B, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New shot aims to silence hepatitis b virus for good

Disease control Not yet recruiting

This study tests an experimental injection called HRS-5635 in adults with chronic hepatitis B whose virus is already controlled by daily pills. The goal is to see if the injection can help the body clear the virus so patients can safely stop all hepatitis B medications. About 540…

Matched conditions: NUCLEOS(T)IDE ANALOGUE-SUPPRESSED HBEAG-NEGATIVE PATIENTS WITH CHRONIC HEPATITIS B

Phase: PHASE3 • Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 12:38 UTC

NUCLEOS(T)IDE ANALOGUE-SUPPRESSED HBEAG-NEGATIVE PATIENTS WITH CHRONIC HEPATITIS B

Get alerted when new NUCLEOS(T)IDE ANALOGUE-SUPPRESSED HBEAG-NEGATIVE PATIENTS WITH CHRONIC HEPATITIS B trials appear

New shot aims to silence hepatitis b virus for good